These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. MR imaging of the normal and abnormal clivus. Kimura F; Kim KS; Friedman H; Russell EJ; Breit R AJR Am J Roentgenol; 1990 Dec; 155(6):1285-91. PubMed ID: 2122682 [TBL] [Abstract][Full Text] [Related]
43. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine. Rofsky NM; Purdy DE; Johnson G; DeCorato DR; Earls JP; Krinsky G; Weinreb JC Radiology; 1997 Jan; 202(1):177-82. PubMed ID: 8988209 [TBL] [Abstract][Full Text] [Related]
44. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. Seeger LL; Widoff BE; Bassett LW; Rosen G; Eckardt JJ AJR Am J Roentgenol; 1991 Aug; 157(2):347-51. PubMed ID: 1853820 [TBL] [Abstract][Full Text] [Related]
45. Digital subtraction in contrast-enhanced MR imaging of the postoperative lumbar spine. Murray JG; Stack JP; Ennis JT; Behan M AJR Am J Roentgenol; 1994 Apr; 162(4):893-8. PubMed ID: 8141014 [TBL] [Abstract][Full Text] [Related]
46. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast. Elster AD; King JC; Mathews VP; Hamilton CA Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413 [TBL] [Abstract][Full Text] [Related]
47. Arterial-phase three-dimensional contrast-enhanced MR angiography of the carotid arteries. Levy RA; Prince MR AJR Am J Roentgenol; 1996 Jul; 167(1):211-5. PubMed ID: 8659374 [TBL] [Abstract][Full Text] [Related]
48. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine. Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238 [TBL] [Abstract][Full Text] [Related]
49. Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. Narumi Y; Kadota T; Inoue E; Kuriyama K; Fujita M; Hosomi N; Sawai Y; Kuroda M; Kotake T; Kuroda C Radiology; 1993 Apr; 187(1):145-50. PubMed ID: 8451401 [TBL] [Abstract][Full Text] [Related]
50. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335 [TBL] [Abstract][Full Text] [Related]
51. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Hamm B; Thoeni RF; Gould RG; Bernardino ME; Lüning M; Saini S; Mahfouz AE; Taupitz M; Wolf KJ Radiology; 1994 Feb; 190(2):417-23. PubMed ID: 8284392 [TBL] [Abstract][Full Text] [Related]
52. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures? Bronen RA AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999 [No Abstract] [Full Text] [Related]
54. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Yousem DM; Som PM; Hackney DB; Schwaibold F; Hendrix RA Radiology; 1992 Mar; 182(3):753-9. PubMed ID: 1535890 [TBL] [Abstract][Full Text] [Related]
55. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476 [TBL] [Abstract][Full Text] [Related]